<p>Cells were treated with the inhibitors at different concentrations for 48 h and counted. Cell viability was assessed using Trypan blue exclusion test. Measured values were fitted by sigmoidal curves using GraphPad Prism 5.0 software. Given EC50 values for inhibition of cell growth and for cell death induction are means and standard deviations from at least 3 independent experiments.</p><p>EC50 values for effects induced by imatinib and dasatinib.</p
IC50values for 38 in vitro models were determined with a semi-automated drug response assay platform...
Doxorubicin was included as a reference compound. Standard deviation for all EC50 values does not ex...
<p>These data represent the means ± SEM. Significantly different from control (*) or combination of ...
<p>HL60 cells were treated with dasatinib for the indicated times. Aliquots of the cultures were wit...
<p>JURL-MK1 (full squares) and JURKAT (empty squares) cells were treated with dasatinib at different...
<p>A, HCC4006ER cells were treated for 72 hours with increasing concentrations of indicated reagents...
<p><b>Abbreviations: CDDP</b>, cisplatin; <b>GEM</b>, gemcitabine; <b>DOC</b>, docetaxel; <b>PTX</b>...
<p>Cytotoxicity assays were performed as described in the “Materials and Methods”. The IC<sub>50</su...
<p>(A) Relative cell viability of IGROV1-CP cells exposed to blank nanoparticles for 72 hours with v...
<p>EC<sub>50</sub>/IC<sub>50</sub> for each parameter measured for the selected cell lines exposed t...
<p>A) Effects of test compounds at different concentrations on HeLa cells following treatment for 24...
<p>Cells were exposed to 0–500 µg/ml Am. At 72 h cells were harvested by trypsinization and the rati...
<p>Cells were treated with various compounds for 4h, and grown for another 20h. (A)IC50 of HeLa and ...
<p>(A) Cells were treated with HSP70 inhibitor, (VER155008) for 72 h. The relative viability and ICs...
<p>(<b>A</b>) Cytotoxicity profile (Plot of % cell death vs concentration of drug at A) 24 hr, B) 48...
IC50values for 38 in vitro models were determined with a semi-automated drug response assay platform...
Doxorubicin was included as a reference compound. Standard deviation for all EC50 values does not ex...
<p>These data represent the means ± SEM. Significantly different from control (*) or combination of ...
<p>HL60 cells were treated with dasatinib for the indicated times. Aliquots of the cultures were wit...
<p>JURL-MK1 (full squares) and JURKAT (empty squares) cells were treated with dasatinib at different...
<p>A, HCC4006ER cells were treated for 72 hours with increasing concentrations of indicated reagents...
<p><b>Abbreviations: CDDP</b>, cisplatin; <b>GEM</b>, gemcitabine; <b>DOC</b>, docetaxel; <b>PTX</b>...
<p>Cytotoxicity assays were performed as described in the “Materials and Methods”. The IC<sub>50</su...
<p>(A) Relative cell viability of IGROV1-CP cells exposed to blank nanoparticles for 72 hours with v...
<p>EC<sub>50</sub>/IC<sub>50</sub> for each parameter measured for the selected cell lines exposed t...
<p>A) Effects of test compounds at different concentrations on HeLa cells following treatment for 24...
<p>Cells were exposed to 0–500 µg/ml Am. At 72 h cells were harvested by trypsinization and the rati...
<p>Cells were treated with various compounds for 4h, and grown for another 20h. (A)IC50 of HeLa and ...
<p>(A) Cells were treated with HSP70 inhibitor, (VER155008) for 72 h. The relative viability and ICs...
<p>(<b>A</b>) Cytotoxicity profile (Plot of % cell death vs concentration of drug at A) 24 hr, B) 48...
IC50values for 38 in vitro models were determined with a semi-automated drug response assay platform...
Doxorubicin was included as a reference compound. Standard deviation for all EC50 values does not ex...
<p>These data represent the means ± SEM. Significantly different from control (*) or combination of ...